Rajesh Ramadurai – Inzpera Healthsciences
View Detailed Executive Profile →Professional Overview
- Rajesh Ramadurai co-founded Inzpera Healthsciences in May 2016, serving as Executive Director and COO, contributing to the establishment of a key player in health sciences.
- Under Rajesh's leadership, Inzpera Healthsciences has focused on innovation in health products, aligning with Tata Industries’ commitment to quality and excellence in various industries.
- Prior to Inzpera, Rajesh held significant roles at Glenmark Pharmaceuticals, including Vice President for the MENA region from July 2013 to February 2016, where strategic growth and market expansion were prioritized.
- As General Manager at Glenmark, Rajesh oversaw the MENA region from April 2013 and was instrumental in enhancing operational efficiency and market penetration.
- Rajesh's experience at Glenmark began as General Manager of Business Planning & Project Management in November 2011, demonstrating strong capabilities in project management and strategic planning.
- Before Glenmark, Rajesh worked with Boehringer Ingelheim from June 2005 to April 2008, where responsibilities included marketing and product management, emphasizing product lifecycle management.
- Rajesh also served as Group Product Manager at Johnson & Johnson from June 2004, focusing on product strategy and market development, showcasing expertise in global healthcare markets.
- Early career experience includes critical roles at Novartis from 1998 to 2001, starting as a Technical Services Executive and advancing to Product Manager, highlighting a strong foundation in pharmaceuticals.
- Throughout the career, Rajesh has faced and overcome challenges in dynamic markets, leveraging skills in leadership, strategic vision, and operational management to drive growth and innovation.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Glenmark Pharmaceuticals | General Manager - Business Planning & Project Management | Nov 2011 – Apr 2013 |
| Boehringer Ingelheim | Mktg. - GPM | Jun 2005 – Apr 2008 |
| Johnson & Johnson | Group Product Manager | Jun 2004 – Jun 2005 |
| Glenmark Pharmaceuticals | Vice President - Head, MENA Region | Jul 2013 – Feb 2016 |
| Novartis | Technical Services Executive | Jul 1998 – Mar 2001 |
| Specialty Ranbaxy Limited | Sales Officer | Jan 1997 – Jan 1998 |
| Glenmark Pharmaceuticals | General Manager, Head - MENA region | Apr 2013 – Jun 2013 |
| Glenmark Pharmaceuticals | General Manager - Corporate Strategy | Apr 2011 – Nov 2011 |
| Glenmark Pharmaceuticals | DGM - Corporate Strategy | Apr 2009 – Mar 2011 |
| Glenmark Pharmaceuticals | Senior Manager - Speciality Strategy | Apr 2008 – Mar 2009 |
| Novartis | Product Manager | Apr 2001 – Jun 2004 |
| Inzpera Healthsciences | Co-founder, Executive Director & COO | May 2016 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Inzpera Healthsciences corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Rajesh Ramadurai's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Inzpera Healthsciences's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)